SOLDURNA Trademark

Trademark Overview

On Monday, September 12, 2022, a trademark application was filed for SOLDURNA with the United States Patent and Trademark Office. The USPTO has given the SOLDURNA trademark a serial number of 97588258. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Friday, March 14, 2025. This trademark is owned by Zoetis Services LLC. The SOLDURNA trademark is filed in the Pharmaceutical Products category with the following description:

Veterinary pharmaceutical, namely, an injectable pain reliever for cats and dogs
soldurna

General Information

Serial Number97588258
Word MarkSOLDURNA
Filing DateMonday, September 12, 2022
Status733 - FOURTH EXTENSION - GRANTED
Status DateFriday, March 14, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 7, 2023

Trademark Statements

Goods and ServicesVeterinary pharmaceutical, namely, an injectable pain reliever for cats and dogs

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 29, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameZoetis Services LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressParsippany, NJ 07054
Party NameZoetis Services LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressParsippany, NJ 07054

Trademark Events

Event DateEvent Description
Thursday, September 15, 2022NEW APPLICATION ENTERED
Wednesday, September 28, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 29, 2022ASSIGNED TO EXAMINER
Thursday, December 29, 2022EXAMINERS AMENDMENT -WRITTEN
Thursday, December 29, 2022EXAMINERS AMENDMENT E-MAILED
Thursday, December 29, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, December 29, 2022EXAMINER'S AMENDMENT ENTERED
Friday, December 30, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 18, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 7, 2023PUBLISHED FOR OPPOSITION
Tuesday, February 7, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 4, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 6, 2023ASSIGNED TO EXAMINER
Thursday, September 14, 2023SOU TEAS EXTENSION RECEIVED
Thursday, September 14, 2023SOU EXTENSION 1 FILED
Thursday, September 14, 2023SOU EXTENSION 1 GRANTED
Saturday, September 16, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 13, 2024SOU EXTENSION 2 GRANTED
Wednesday, March 13, 2024SOU EXTENSION 2 FILED
Wednesday, March 13, 2024SOU TEAS EXTENSION RECEIVED
Thursday, March 14, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 3, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, September 3, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 3, 2024SOU EXTENSION 3 FILED
Tuesday, September 3, 2024SOU EXTENSION 3 GRANTED
Friday, March 14, 2025SOU TEAS EXTENSION RECEIVED
Friday, March 14, 2025SOU EXTENSION 4 FILED
Friday, March 14, 2025SOU EXTENSION 4 GRANTED
Saturday, March 15, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

soldurna reliever cats dogs pain injectable pharmaceutical namely veterinary